Parallel channel for the short term.I've used a parallel channel to try and see if we stay within this range. It appears to be bullish for now, I'd like to see us stay within it for another week. Though HUT sometimes has some rapid moves.
First chart ever, is this meaningful at all?I'm trying to learn how to find meaningful points on a chart. I figured I'd pick one of my losing trades in the past and hopefully make it profitable in the future. Any input on my points of intersection and general trend lines would be helpful.
WPRT Daily TimeFrame Analysis (ID 1)✳️Position ID: 1
📈Stock: WPRT
🏦Exchange: TSX
⚖️Leverage: 0% (x:x)
💰Price: 1.45$
🔥Quantity: 50
🐃Position: Long
⏱Duration: 6 months to 5 years
💥Upside: 160.00% at 3.77$
*Info based of Q1 2022
I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
I will not and cannot be held liable for any actions you take as a result of anything you read here.
Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.
I reflects my own views, ideas and opinions. It is not a production of my employer, nor is it affiliated with any broker/dealer or registered investment advisor.
No representations or warranties are made with respect to the accuracy or completeness of the content of this entire weblog, including any links to other sites. The links provided are maintained by their respective organizations and they are solely responsible for their content. All information presented here is provided ‘as is’, without warranty of any kind, expressed or implied.
From time to time I may include affiliate links and advertisements that result in my receiving a payment should a visitor click on a link or sign up to a service, as per established Internet practice. Readers are entirely responsible for any actions they take as a result of reading or clicking on links on the site, and are urged to read the small print!
Bearish market is changing the rulesIt seems like all trading rules are out of control in this bearish market. One of the Greatest investors of all time Warren Buffett said "be greedy when others are fearful; and be fearful when others are Greedy" this rings true in the mind. However Buffer was an investor & not a traders. the rules differ or both games.
THIS IS ONE OF MY BEST & MOST PROFITABLE trades.
short term (W) is in correction while longterm (M) still technically in uptrend. price comes into the DZ which is the HL (Higher Low) of the
longterm (M) chart. provide low risk entry & high profit.
It seems in this market nothing hold true. As the price broke through the DZ. I followed my rules and took the Loss.
If there is a lesson to carry. the DZ was tested (in the dark square) this basically weakens the
DZ. One of my first trading teacher compared a DZ to a door. the more you knock on the door the more likely it will break down. This DZ door has been knocked before. it broke & the door opened. A better trade enhancer would of been a fresh untested DZ
CPG - bullish entry pattern, medium riskIf it holds 10 days EMA level. Upcoming earnings risk is offset by: it held very strong support and formed a bollinger band top. I think it will be up post earnings, up to the upper band
$IBO announced a vital addition of clinical trials director
Julie Dumouchel has been named Director of Clinical Trials at UI, which is a significant strategic move. Julie Dumouchel has 25 years of experience in the pharmaceutical sector, where she has worked in a variety of clinical research jobs and has a thorough grasp of the drug development process.
$IBO propagating effortlessly, investors under the clutch
$IBO has exceptional potential when it comes to volatility, and the share prices have been hiking lately, last closing of the stock trading at $0.0400 on TSX-V with a noted spike
AC Daily TimeFrame Analysis (ID 2)✳️Position ID: 2
📈Stock: AC
🏦Exchange: TSX
⚖️Leverage: 0% (x:x)
💰Price: 17.31$
🔥Quantity: 2
🐃Position: Long
⏱Duration: 6 months to 5 years
💥Upside: 29.31% at 22.38$
*Info based of Q1 2022
I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
I will not and cannot be held liable for any actions you take as a result of anything you read here.
Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.
I reflects my own views, ideas and opinions. It is not a production of my employer, nor is it affiliated with any broker/dealer or registered investment advisor.
No representations or warranties are made with respect to the accuracy or completeness of the content of this entire weblog, including any links to other sites. The links provided are maintained by their respective organizations and they are solely responsible for their content. All information presented here is provided ‘as is’, without warranty of any kind, expressed or implied.
From time to time I may include affiliate links and advertisements that result in my receiving a payment should a visitor click on a link or sign up to a service, as per established Internet practice. Readers are entirely responsible for any actions they take as a result of reading or clicking on links on the site, and are urged to read the small print!
$50M - $55M USD 2022 revenue guidance; $8M CAD market cap!Simply Better Brands Corp. Raises 2022 Financial Outlook as Year to Date Preliminary Results Exceed Expectations
by @GlobeNewswire on 13 Jul 2022, 09:02
2022 Outlook
As a result of the strong year to date and quarter to date preliminary results as of June 30, 2022, the Company's guidance is changing as follows:
- Expected consolidated net sales are increased to $50 million-55 million from $40 million-$42 million.
- Expected gross margin as a percentage of net sales is increased to 63%-65% from 58-60%.
- The Company continues its expectation to achieve positive Adjusted EBITDA for fiscal 2022.
$IBO the globally renowned stock investment trading at max speed
$IBO don’t ever shy out from attaining peaks in the market and delivering unimaginable profit to the shareholders, the shares are trading yesterday with a massive spike of 11.11%, at $0.05 with substantial incline
$DIA oozing with oodles of profit in the market, don't miss the
$DIA, an exploration stage company, engages in the exploration and acquisition of mineral properties in Canada, and is currently trading at $0.1750, with a great jump in the market. As per the charts the stock is expected to follow a bullish pattern.
HUGE BUY - Palangio PX Was at $12.50, now .03 PUMP OF THE CENTURY!!!
Jr. exploree of gold and base metals in Canada and Ghana .
$IBO trading at its all time high, an offer you cannot refuse bu
$IBO don’t ever shy out from attaining peaks in the market and delivering unimaginable profit to the shareholders, the shares are trading with a massive spike at $0.045 with substantial incline
$IBO a stock lock and loaded with profit and momentum on the TSX
$IBO is moving ahead with courage and compassion on the TSX-V, the stock is rising in leaps and bounds in the market, shares are effectively trading at $0.045 with a rise in value
$IBO ahead with a beguiling stock presentation in the market
$IBO has exceptional potential when it comes to volatility, and the share prices have been hiking lately,
$IBO with an enlivening incline on the TSX-V, Best bargain in th
$IBO is currently trading with enormous pace and is trying to disrupt its target price before time with every piece of effort it can foster, the shares are trading at $0.045 with volume of 24k
$IBO with an exhilarating ascent on the TSX-V, Best bargain in t
$IBO is currently trading with enormous pace and is trying to disrupt its target price before time with every piece of effort it can foster, the shares are trading at $0.05
FNV - Weekly - Great place to buy or add!The setup looks good to me on the weekly chart on this really fantastic long-term winning stock. The weekly RSI is beginning to approach oversold/fair value levels and the Williams Vix Fix indicator is now signaling a bottom as well. In terms of price, we may double bottom in the low 160s support zone so the downside risk feels more minimal at this point and should be temporary. Personally for these reasons I am adding to my long-term position at this level as we have now seen a nice 20%+ correction since the previous run-up earlier in the year. In an environment with rising rates, not much beats owning a company with NO debt/leverage eating away at their cashflows.
$HEM declared the addition of an entirely closely-held subsidiar
Hemostemix recently declared the incorporation of PreCerv inc . (A totally closely-held subsidiary of Hemostemix). Hemostemix can grant PreCerv a world field of use licence for NCP-01 and its autologous somatic cell technology to treat central and peripheral systema nervosum diseases.
$HEM grants worldwide field license to PreCerv Inc.
Hemostemix recently granted the global field license of use of NCP-01 and its autologous stem cell therapies to PreCerv Inc. its wholly owned subsidiary to aid patients with peripheral and central nervous system conditions
Tut Fitness Group Canada Sun Storm Investment Trading Desk & NexGen Wealth Management Service Present's: SSITD & NexGen Portfolio of the Week Series
Focus: Worldwide
By Sun Storm Investment Research & NexGen Wealth Management Service
A Profit & Solutions Strategy & Research
Trading | Investment | Stocks | ETF | Mutual Funds | Crypto | Bonds | Options | Dividend | Futures |
USA | Canada | UK | Germany | France | Italy | Rest of Europe | Mexico | India
Disclaimer: Sun Storm Investment and NexGen are not registered financial advisors, so please do your own research before trading & investing anything. This is information is for only research purposes not for actual trading & investing decision.
#debadipb #profitsolutions
Canadian National RailwaySun Storm Investment Trading Desk & NexGen Wealth Management Service Present's: SSITD & NexGen Portfolio of the Week Series
Focus: Worldwide
By Sun Storm Investment Research & NexGen Wealth Management Service
A Profit & Solutions Strategy & Research
Trading | Investment | Stocks | ETF | Mutual Funds | Crypto | Bonds | Options | Dividend | Futures |
USA | Canada | UK | Germany | France | Italy | Rest of Europe | Mexico | India
Disclaimer: Sun Storm Investment and NexGen are not registered financial advisors, so please do your own research before trading & investing anything. This is information is for only research purposes not for actual trading & investing decision.
#debadipb #profitsolutions
